Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Gains from Sales and Divestitures (2020 - 2025)

Catheter Precision has reported Gains from Sales and Divestitures over the past 5 years, most recently at $17263.0 for Q4 2025.

  • Quarterly Gains from Sales and Divestitures changed N/A to $17263.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17263.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $17263.0 for FY2025, N/A changed from the prior year.
  • Gains from Sales and Divestitures was $17263.0 for Q4 2025 at Catheter Precision, up from $11263.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $100000.0 in Q2 2025 and troughed at $26.0 in Q1 2023.
  • The 4-year median for Gains from Sales and Divestitures is $11263.0 (2025), against an average of $20175.4.
  • Year-over-year, Gains from Sales and Divestitures crashed 99.63% in 2022 and then soared 22122.22% in 2023.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $31388.0 in 2021, then crashed by 99.63% to $117.0 in 2022, then crashed by 77.78% to $26.0 in 2023, then soared by 66296.15% to $17263.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Gains from Sales and Divestitures are $17263.0 (Q4 2025), $11263.0 (Q3 2025), and $100000.0 (Q2 2025).